Types of Human Lung Tumor Cell Lines and Urokinase Expression
Author Information
Author(s): R. Schwartz-Albiez, H.-H. Heidtmann, D. Wolf, V. Schirrmacher, G. Moldenhauer
Primary Institution: German Cancer Research Center
Hypothesis
Can the surface expression of urokinase-type plasminogen activator (u-PA) help distinguish between different types of human lung tumors?
Conclusion
The study found that different lung tumor cell lines exhibit varying abilities to express and bind u-PA, which may reflect their growth behavior and origin.
Supporting Evidence
- Three groups of lung tumor cell lines were identified based on their u-PA expression and binding ability.
- NSCLC cell lines expressed u-PA and bound it, while SCLC lines did not express or bind u-PA.
- Mesothelioma cell lines did not express u-PA but could bind it.
Takeaway
This study looked at how different lung cancer cells use a protein called urokinase, which helps them grow and spread. Some cancer cells use it a lot, while others don't use it at all.
Methodology
The study used a cellular radioimmunoassay (CRIA) to measure the surface expression of u-PA and its binding capacity in various lung tumor cell lines.
Limitations
The study primarily focused on in vitro cell lines, which may not fully represent in vivo tumor behavior.
Want to read the original?
Access the complete publication on the publisher's website